Reducing empiric piperacillin-tazobactam use for patients with community-acquired intra-abdominal infections
Claire Wilson1, Kevin Epps1, Courney Willis1
1Mayo Clinic in Florida, USA.
Objectives:
Community-acquired intra-abdominal infections (CA-IAIs) are a leading cause of US hospitalizations. Piperacillin-tazobactam is often used to empirically treat CA-IAIs, despite national guidelines recommending narrower-spectrum antibiotics for these infections. The overuse of broad-spectrum agents such as piperacillin-tazobactam contributes to antibiotic resistance, which poses serious public health challenges. This resident-led quality improvement initiative aimed to reduce unnecessary piperacillin-tazobactam use for treating CA-IAIs measured as DOT/1,000 patient-days by 10% without adversely affecting hospital length of stay (LOS).
Methods:
Using the DMAIC (define, measure, analyze, improve, control) framework, we identified barriers to appropriate antibiotic use and developed a treatment algorithm for CA-IAIs that included clear guidelines and exclusion criteria. This algorithm was disseminated to internal medicine residents and emergency department physicians along with educational sessions to highlight updated CA-IAI treatment recommendations, antibiotic resistance, and appropriate antibiotic ordering via the electronic health record. Antimicrobial stewardship pharmacists provided overnight support to assist with de-escalation. Data were collected over a 10-month period spanning 2 intervention phases. The primary outcome was piperacillin-tazobactam use, measured as days of therapy (DOT) per 1,000 patient-days and DOT per patient LOS. Mean LOS served as the balancing measure.
Results:
Piperacillin-tazobactam use was significantly reduced (P < .001) after the interventions without increasing the mean LOS.
Conclusion:
This project raised awareness of antibiotic resistance and led to lasting improvements in reducing the inappropriate use of piperacillin-tazobactam to treat CA-IAIs, without affecting the mean LOS. This was attributed to the strong collaboration among a multidisciplinary team of infectious disease physicians, antimicrobial stewardship team members, residents, emergency department physicians, and faculty.
Insights
A quality improvement initiative successfully reduced broad-spectrum antibiotic use for community-acquired intra-abdominal infections (CA-IAIs). This initiative lowered piperacillin-tazobactam use without impacting patient length of stay, addressing antibiotic resistance concerns.
Area of Science:
- Infectious Diseases
- Antimicrobial Stewardship
- Quality Improvement
Background:
- Community-acquired intra-abdominal infections (CA-IAIs) are a significant cause of hospitalization in the US.
- Current practices often involve empirical use of broad-spectrum antibiotics like piperacillin-tazobactam, despite guidelines recommending narrower agents.
- Overuse of broad-spectrum antibiotics contributes to antimicrobial resistance, a critical public health issue.
Purpose of the Study:
- To decrease the utilization of piperacillin-tazobactam for CA-IAIs by 10% within a hospital setting.
- To achieve this reduction without negatively affecting the average hospital length of stay (LOS).
- To enhance the appropriate prescribing of antibiotics for CA-IAIs through a resident-led initiative.
Main Methods:
- The DMAIC (define, measure, analyze, improve, control) framework guided the quality improvement project.
- A treatment algorithm for CA-IAIs was developed and disseminated, including educational sessions for physicians and residents.
- Antimicrobial stewardship pharmacists provided support for antibiotic de-escalation, with data collected over a 10-month period.
Main Results:
- A statistically significant reduction in piperacillin-tazobactam use (measured in DOT/1,000 patient-days) was observed post-intervention (P < .001).
- The average hospital length of stay (LOS) did not increase, serving as a key balancing measure.
- The interventions effectively decreased the use of broad-spectrum antibiotics for CA-IAIs.
Conclusions:
- The initiative successfully raised awareness regarding antibiotic resistance and improved the appropriate use of piperacillin-tazobactam for CA-IAIs.
- Lasting improvements were achieved without compromising patient length of stay.
- Multidisciplinary collaboration was crucial to the project's success.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Urinary Tract Infection IV: Nursing Management
Urine Studies II: Urine Culture and Sensitivity Test
Clinical Significance of Antibiotic Resistance
Combined Effects of Drugs: Synergism
Such synergistic combinations...


